Denali Therapeutics
DNLI
#3422
Rank
ยฃ2.61 B
Marketcap
ยฃ18.18
Share price
-0.54%
Change (1 day)
5.80%
Change (1 year)

Revenue for Denali Therapeutics (DNLI)

Revenue in 2024 (TTM): N/A

In 2023 the company made a revenue of ยฃ0.25 Billion an increase over the revenue in the year 2022 that were of ยฃ89.65 Million. The revenue is the total amount of income that a company generates by the sale of goods or services. Unlike with the earnings no expenses are subtracted.

Revenue history for Denali Therapeutics from 2017 to 2024

Annual revenue

Year Revenue Change
2024 (TTM) N/A-100%
2023 ยฃ0.25 B189.38%
2022 ยฃ89.65 M148.7%
2021 ยฃ36.04 M-85.36%
2020 ยฃ0.24 B1110.41%
2019 ยฃ20.34 M-80.01%
2018 ยฃ0.10 B
2017 N/A

Revenue for similar companies or competitors

Company Revenue Revenue differencediff. Country
ยฃ0.45 BN/A Jersey
ยฃ0.66 BN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ0.08 MN/A๐Ÿ‡บ๐Ÿ‡ธ USA
ยฃ17.19 MN/A๐Ÿ‡ฌ๐Ÿ‡ง UK